PDCD1 and lupus nephritis: In murine models of lupus nephritis, treatment with PD-1 inhibitors reduces CD4+ PD1+ cell count and overall mortality rate, while PD-L1 inhibition increases inflammatory cytokines and autoantibody titers and accelerates renal damage (Kasagi et al., 2010).